Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients

Biomedicine and Pharmacotherapy

Volumn 60, Issue 10, 2006, Pages 663-672

  Kojima, M ^a,b   Motoori, T ^c   Nakamura, S ^d  

^a GUNMA CANCER CENTER HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; Lymph node; Lymphoproliferative disorders; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; MIZORIBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; B CELL LYMPHOMA; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOBLASTIC LYMPHOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH FOLLICLE; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE HYPERPLASIA; LYMPHADENOPATHY; LYMPHOMA; LYMPHOPLASMACYTIC IMMUNOBLASTIC PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; PLASMACYTOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX RATIO; SIDE EFFECT; NONHODGKIN LYMPHOMA; PATHOLOGY; PRECANCER; REVIEW; RISK FACTOR; VIRUS INFECTION;

ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 34249745413     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.09.004     Document Type: Article

References (44)

1. Kumar V., Cotran R.S., and Robbins S.L. Basic pathology. 7th ed (2003), W.B. Saunders, Philadelphia 103-164
2. Motulsky A.G., Weinberg S., Saphir O., and Rosenberg E. Lymph nodes in rheumatoid arthritis. Arch. Intern. Med. 90 (1952) 660-672
3. Nosanchuk J.S., and Schnitzer B. Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study. Cancer 24 (1969) 343-354
4. Henry K. Connective tissue disorders/autoimmune diseases. In: Henry K., and Symmers W.S.T.C. (Eds). Thymus, lymph nodes, spleen and lymphatics. Systemic pathology, vol 7. 3rd ed (1992), Churchill Livingstone, Edinburgh 255-263
5. McCluggage W.G., and Bharucha H. Lymph node hyalinization in rheumatoid arthritis and systemic sclerosis. J. Clin. Pathol. 47 (1994) 138-142
6. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles D.M. (Ed). Neoplastic hematopathology. 2nd ed (2000), Lippincott Williams and Wilkins, Baltimore 569-622
7. Ioachim H.L., and Pathch H. Ioachim's lymph node pathology. 3rd ed (2002), Lippincott Williams and Willkins, Philadelphia
8. Ben-Chetrit E., Flusser D., Okon E., Ackerman Z., and Rubinow A. Multicentric Castleman's disease assocoiated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann. Rheum. Dis. 48 (1989) 326-330
9. Kojima M., Nakamura S., Oyma T., Motoori T., Itoh H., Yoshida K., et al. Autoimmune disease-associated lymphadenopathy with hiostological appearance of T-zone dysplasia with hyperplastic follicles. A clinicopathologic analysis of nine cases. Pathol. Res. Pract. 197 (2001) 237-244
10. Koo C.H., Nathwani B.N., Winberg C.D., Hill L.R., and Rappaport H. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore) 63 (1984) 274-290
11. Kojima M., Motoori T., Hosomura Y., Tanaka H., Sakata N., and Masawa N. Atypical lymphoplasmacytic and immunoblastic proliferation from rheumatoid arthritis. A case report. Pathol. Res. Pract. 202 (2006) 51-54
12. Isomäki H.A., Hakulinen T., and Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J. Chronic Dis. 31 (1978) 691-696
13. Symmons D.P.M. Neoplasms of the immune system in rheumatoid arthritis. Am. J. Med. 78 Suppl IA (1985) 22-28
14. Thomas E., Brewster D.H., Black R.J., and Macfarlane G.J. Risk of malignancy among patients with rheumatic conditions. Int. J. Cancer 88 (2000) 497-502
15. Leandro M.J., and Isenberg D.A. Rheumatic diseases and malignancy-is there an association. Scand. J. Rheumatol. 30 (2001) 185-188
16. Kamel O.W., van de Rijn M., LeBrun D.P., Weiss L.M., Warnke R.A., and Dorfman R.F. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum. Pathol. 25 (1994) 638-643
17. Kamel O.W., Weiss L.M., van de Rijin M., Colvy T.V., Kingma D.W., and Jaffe E.S. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am. J. Surg. Pathol. 20 (1996) 1279-1287
18. Kamel O.W. Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin. Diag. Pathol 14 (1997) 27-34
19. Harris N.L., and Swerdlow S.L. Methotrexate-associated lymphoproliferative disorders. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 270-271
20. Banks P.M., Witrak G.A., and Conn D.L. Lymphoid neoplasia following connective tissue disease. Mayo Clin. Proc. 54 (1979) 104-108
21. Symmons D.P.M., Ahern M., Bacon P.A., Hawkins C.F., Amlot P.L., Jones E.L., et al. Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann. Rheum. Dis. 43 (1984) 132-135
22. Kamel O.W., Holly E.A., van de Rijin M., Lele C., and Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J. Rheumatol. 29 (1999) 1676-1680
23. Baecklund E., Sundström C., Ekbonm A., Catrina A.I., Biberfeld P., Feltelius N., et al. Lymphoma subtypes in patients with rheumatoid arthritis. Increased proportion of diffuse large B cell lymphoma. Arthritis Rheum. 48 (2003) 1543-1550
24. Hoshida Y., Tomita Y., Zhiming D., Yamauchi A., Nakatsuka S.-I., Kurasono Y., et al. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathologic features and Epstein-Barr virus infection. Int. J. Cancer 108 (2004) 443-449
25. Kojima M., Itoh H., Shimizu K., Saruki N., Murayama K., Higuchi K., et al. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and dermatomyositis): a clinicopathologic study of 24 Japanese cases. Int. J. Surg. Pathol. 14 (2006) 43-48
26. Kojima M., Itoh H., Hirabayashi K., Igarashi S., Tamaki Y., Murayama K., et al. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol. Res. Pract. 203 (2006) 679-685
27. Fox D.A. Etiology and pathogenesis of rheumatoid arthritis. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and allied conditions. A textbook of rheumatology. 15th ed (2005), Lippincott Williams and Willkins, Philadelphia 1089-1115
28. Kojima M., Hosomura Y., Itoh H., Johshita T., Yoshida K., Nakamura S., et al. Reactive proliferative lesions in lymph node from rheumatoid arthritis patients. A clinicopathological study and immunohistochemical study. Acta Pathol. Jpn. 40 (1990) 249-254
29. Imai Y., and Yamakawa M. Morphology, function and pathology of follicular dendritic cells. Pathol. Intern. 46 (1996) 807-833
30. Numata Y., Matsura Y., Onishi S., Yamamoto Y., Ohno F., Tagoh H., et al. Interleukin-6 positive follicular hyperplasia in the lymph node of a patient with rheumatoid arthritis. Am. J. Hematol. 36 (1991) 282-284
31. Humphrey D.M., Cortez E.A., and Spiva D.A. Immunohistologic studies of cytoplasmic immunoglobulins in rheumatic diseases including two patients with monoclonal patterns and subsequent lymphoma. Cancer 49 (1982) 2049-2069
32. Kojima M., Motoori T., Itoh H., Shimizu K., Iijima M., Tamaki Y., et al. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis) with associated lymphadenopathy. A study of 49 cases. Int. J. Surg. Pathol. 13 (2005) 273-278
33. Niedobitek G., Herbst H., Young L.S., Brooks L., Masucci M.G., Crocker J., et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79 (1992) 2520-2526
34. Kojima M., Nakamura S., Nishikawa M., Itoh H., Miyawaki S., and Masawa N. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases. Pathol. Res. Pract. 201 (2005) 325-332
35. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
36. Feller A.C., and Diebold J. Histopathology of nodal and extranodal non-Hodgkin's lymphomas (2004), Springer, Berlin
37. Ree H.J., Kadin M.E., Kikuchi M., Ko Y.H., Go J.H., Suzumiya J., et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am. J. Surg. Pathol. 22 (1998) 643-655
38. Kojima M., Nakamura S., Itoh H., Motoori T., Sugihara S., Shinkai H., et al. Angioimmunoblastic T cell lymphoma with hyperplastic germinal centers: a clinicopathological and immunohistochemical study of 10 cases. APMIS 109 (2001) 699-706
39. Blanco R., McLaren B., Davis B., Steele P., and Smith R. Systemic lupus erythematosus-associated lymphoproliferative disorder: report of a case and discussion in light of the literature. Hum. Pathol. 28 (1997) 980-985
40. Salloum E., Cooper D.L., Howe G., Lacy J., Talloni G., Crouch J., et al. Spontenous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J. Clin. Oncol. 14 (1996) 1943-1949
41. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphoma in Japan: incidence of recently recognized entities. Pathol. Intern. 50 (2000) 696-702
42. Allzadeh A.A., Elsen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., et al. Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 40 (2000) 503-511
43. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
44. Plater-Zyberk C., Maini R.N., Lam K., Kennedy T.D., and Janossy G. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytoc leukemia. Arthrits Rheum. 28 (1985) 971-976